Back to search

Peptide record

TPDB08550

Antibacterial Anticancer Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08550
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 17-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KGCALVKVRGLTLKVCK
Physicochemical Analysis
C80H150N24O19S2
NDEQHIMFPSWY
K
1816.34
10.55
5
0
7
+5
2.81
0.541
125.88
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
125
6.88
3
Residue Composition
number
1
A
1
R
0
N
0
D
2
C
0
E
0
Q
2
G
0
H
0
I
3
L
4
K
0
M
0
F
0
P
0
S
1
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 2 H: 0 I: 0 L: 3 K: 4 M: 0 F: 0 P: 0 S: 0 T: 1 W: 0 Y: 0 V: 3
Chemical Descriptors
17
C80H150N24O19S2
1816.34
10.55
+5
2.81
0.541
Evidence Records 7 records
Evidence 1 Activity

Activity

12% Hemolysis
Toxicity
500 µg/mL
Hemolytic Cytotoxic
12% Hemolysis | 500 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. | J Pept Sci | 2013
Evidence 2 Activity

Activity

4% Hemolysis
Toxicity
250 µg/mL
Hemolytic Cytotoxic
4% Hemolysis | 250 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. | J Pept Sci | 2013
Evidence 3 Activity

Activity

2% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
2% Hemolysis | 100 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. | J Pept Sci | 2013
Evidence 4 Activity

Activity

1% Hemolysis
Toxicity
12.5 µg/mL
Hemolytic Cytotoxic
1% Hemolysis | 12.5 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. | J Pept Sci | 2013
Evidence 5 Activity

Activity

3% Cytotoxicity
Toxicity
100 µg/mL
Cytotoxic
3% Cytotoxicity | 100 | µg/mL | target cell: Human umbilical vein endothelial cells HUVEC

Target

Human umbilical vein endothelial cells HUVEC

Source & Reference

NA
DBAASP
In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. | J Pept Sci | 2013
Evidence 6 Activity

Activity

4% Cytotoxicity
Toxicity
100 µg/mL
Cytotoxic
4% Cytotoxicity | 100 | µg/mL | target cell: Human fibroblasts WI-38

Target

Human fibroblasts WI-38

Source & Reference

NA
DBAASP
In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. | J Pept Sci | 2013
Evidence 7 Activity

Activity

% Hemolysis
Toxicity
1 %
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.23893489] <1% hemolysis at 1 µg/ml , <1% hemolysis at 12.5 µg/ml , 1.5% hemolysis at 100 µg/ml , 4.2% hemolysis at 250 µg/ml , 12.0% hemolysis at 500 µg/ml against sheep red blood cells | Cytotoxicity: [Ref.23893489] The cytotoxicity (vs control) of P72 is 3% against HUVEC (endothelial) cells at a peptide concentration of 100 µg/ml. ##The cytotoxicity (vs control) of P72 is 4% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 µg/ml. #

Target

erythrocytes

Source & Reference

NA
DRAMP
J Pept Sci. 2013 Sep 19(9):554-65. doi: 10.1002/psc.2532.